ProCE Banner Series

The Pivotal Role of the Primary Care Provider in Managing Patients With Cardiorenal Metabolic Diseases

Join us for an interactive, case-based discussion where experts in primary care, heart failure, and chronic kidney disease discuss the importance of integrating SGLT2 inhibitors into daily practice. Gain insight into the benefits of SGLT2 inhibitors beyond their use in type 2 diabetes, discuss clinical evidence for use in heart failure and chronic kidney disease, and implement strategies to mitigate adverse events while optimizing patient care.

  AAPA
  | AMA
  | ANCC
Who Should Attend

This program is intended for primary care physicians, PAs, NPs, and other HCPs who manage patients with cardiorenal metabolic comorbidities.

All Events

The Pivotal Role of the Primary Care Provider in Managing Patients With Cardiorenal Metabolic Diseases

Past Events

November

14

2023

6:00 PM - 7:00 PM Central Time (CT)

Virtual

December

05

2023

6:00 PM - 7:00 PM Pacific Time (PT)

Virtual

January

11

2024

6:00 PM - 7:00 PM Pacific Time (PT)

Virtual

February

06

2024

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

February

20

2024

6:00 PM - 7:00 PM Central Time (CT)

Virtual

April

11

2024

8:00 PM - 9:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Nayan Arora, MD

Assistant Clinical Professor
Division of Nephrology
Clinical Lead of the Diabetic Kidney Clinic and inpatient cardiorenal service
University of Washington
Seattle, Washington

ProCE Banner Faculty
Ty J. Gluckman, MD, MHA

Medical Director
Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence Health System
Portland, Oregon

ProCE Banner Faculty
Kim Pfotenhauer, DO, FACOFP

Assistant Dean of Clerkship Education
Assistant Professor of Family Medicine
Michigan State University
College of Osteopathic Medicine
East Lansing, Michigan

ProCE Banner Faculty
Jay H. Shubrook, DO, FACOFP, FAAFP

Professor
Department of Clinical Sciences and Community Health
Diabetologist
Touro University California College of Osteopathic Medicine
Vallejo, California

ProCE Banner Faculty
Eugene Wright, MD

Medical Director for Performance Improvement
South Piedmont Ares Health Education Center (AHEC)
Charlotte, NC
Consulting Associate 
Department of Medicine
Duke University Medical Center
Durham, NC

Topics

Introductions and Polling

Overview of Cardiorenal Metabolic Disease

Overview of SGLT2 Inhibitors

Case-Based Discussions Highlighting Guidelines and Clinical Evidence

Closing and Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Program Overview
The primary purpose of this program is to arm healthcare professionals with the tools necessary to integrate SGLT2 inhibitors across a broad spectrum of patients, including those with diabetes, heart failure, and chronic kidney disease. 

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with cardiorenal metabolic diseases.

Target Audience
This program is intended for primary care physicians, PAs, NPs, and other HCPs who manage patients with cardiorenal metabolic comorbidities.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess the effects of SGLT2 inhibitors beyond glycemic management for patients with cardiorenal metabolic comorbidities
  • Integrate different SGLT2 inhibitors into the treatment for patients with diabetes, HF, and CKD based on clinical evidence and guideline recommendations
  • Implement strategies to collaboratively mitigate adverse effects and optimize access for patients with indications for SGLT2 inhibitors

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company.